Liflex Science Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $5.23M

  • Investors
  • 10

Liflex Science General Information

Description

Developer of RNA therapeutics designed for the fundamental recovery of osteoarthritis sites. The company utilizes a microRNA degradation platform and antisense oligonucleotide technology, enabling medical institutions to provide treatments that induce cartilage regeneration and address degenerative arthritis.

Contact Information

Website
www.liflex.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room B-330, Gwanak 500-dong, 1Gwanak-ro
  • Graduate Reasearch Building Phase 2, Gwanak-gu
  • Seoul, Sillim
  • South Korea
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Vertical(s)
Life Sciences
Corporate Office
  • Room B-330, Gwanak 500-dong, 1Gwanak-ro
  • Graduate Reasearch Building Phase 2, Gwanak-gu
  • Seoul, Sillim
  • South Korea

Liflex Science Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Liflex Science Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series A) 10-Nov-2026 $5.23M Completed Generating Revenue
2. Accelerator/Incubator 01-May-2024 Completed Generating Revenue
1. Corporate 30-Nov-2023 Completed Generating Revenue
To view Liflex Science’s complete valuation and funding history, request access »

Liflex Science Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Liflex Science Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Korea Development Bank VC-Backed Company Minority
Korea Science & Technology Holdings Venture Capital Minority
Medytox Corporation Minority
Mirae Science and Technology Venture Capital Minority
Murex Partners Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Ready to get started?

Request a free trial

Liflex Science FAQs

  • When was Liflex Science founded?

    Liflex Science was founded in 2021.

  • Where is Liflex Science headquartered?

    Liflex Science is headquartered in Seoul, South Korea.

  • What is the size of Liflex Science?

    Liflex Science has 9 total employees.

  • What industry is Liflex Science in?

    Liflex Science’s primary industry is Biotechnology.

  • Is Liflex Science a private or public company?

    Liflex Science is a Private company.

  • What is Liflex Science’s current revenue?

    The current revenue for Liflex Science is .

  • How much funding has Liflex Science raised over time?

    Liflex Science has raised $5.23M.

  • Who are Liflex Science’s investors?

    Korea Development Bank, Korea Science & Technology Holdings, Medytox, Mirae Science and Technology, and Murex Partners are 5 of 10 investors who have invested in Liflex Science.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process